The EP4 antagonist vorbipiprant and an anti-PD-1 in MSS mCRC
收藏NIAID Data Ecosystem2026-05-02 收录
下载链接：
https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE281374
下载链接
链接失效反馈官方服务：
资源简介：
The aim of the study was to determine whether vorbipiprant, a prostaglandin EP4 receptor antagonist, can convert immune-resistant mCRC into a tumor responsive to anti-PD-1 inhibition Samples from human biopsies or surgical resection of primary tumor were analyzed in order to identify potential predictors of clinical response.
创建时间：
2025-02-11
